After grabbing 9.5 million shares, the institutional investor is now in possession of 9.5 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 3.77% having worth around $11.5 million. Moreover, BlackRock Fund Advisors increased its share by 1.33 million to have a control over 8.41 million shares. And The Vanguard Group, Inc. raised its holdings to 1.71 million shares by acquiring 6.38 million shares or 2.53% of the stake.
Precigen Inc. (PGEN) concluded trading on 05/24/23 at a closing price of $1.32, with 1.39 million shares of worth about $1.84 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.25% during that period and on Wednesday the price saw a loss of about -5.71%. Currently the company’s common shares owned by public are about 229.77M shares, out of which, 183.37M shares are available for trading.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 46 times over the past 12 months. They bought 14,168,405 shares in 45 of the transactions. In 1 selling transactions, insiders dumped 50,000 shares.
Opportunity Trust, Vanguard Total Stock Market ETF, and iShares Russell 2000 ETF are the top 3 mutual funds which are holding stakes in Precigen Inc. Opportunity Trust is currently holding 8.5 million shares of worth totaling $10.29 million. The company recently came buying 8.5 million shares which brought its stake up to 3.37% of the company’s outstanding shares. iShares Russell 2000 ETF, after selling 2.63 million shares, have now control over 1.04% of the stake in the company. It holds 38480.0 shares of worth $3.19 million.
Precigen Inc. (NASDAQ: PGEN) started trading at $1.43, above $0.03 from concluding price of the previous day. However, the stock later moved at a day high price of 1.4300, or with a loss of -5.71%. Stock saw a price change of 7.32% in past 5 days and over the past one month there was a price change of 16.81%. Year-to-date (YTD), PGEN shares are showing a performance of -13.16% which increased to 5.60% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.81 but also hit the highest price of $2.90 during that period. The average intraday trading volume for Precigen Inc. shares is 1.49 million. The stock is currently trading 8.64% above its 20-day simple moving average (SMA20), while that difference is up 18.08% for SMA50 and it goes to -20.41% lower than SMA200.
Miller Value Partners LLC acquired 9.5 million shares of Precigen Inc. having value of about $11.5 million. Precigen Inc. (NASDAQ: PGEN) currently have 229.77M outstanding shares and institutions hold larger chunk of about 60.50% of that. Holding of mutual funds in the company is about 12.21% while other institutional holders and individual stake holders have control over 49.03% and 11.95% of the stake respectively.
The stock has a current market capitalization of $326.83M and its 3Y-monthly beta is at 1.95. It has posted earnings per share of -$0.38 in the same period. It has a debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PGEN, volatility over the week remained 9.18% while standing at 8.59% over the month.
Analysts are in expectations that Precigen Inc. (PGEN) stock would likely to be making an EPS of -$0.1 in the current quarter, while forecast for next quarter EPS is -$0.11 and it is -$0.43 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.11 which is -$0.09 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.09 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 28.90% while it is estimated to decrease by -7.10% in next year. EPS is likely to grow at an annualized rate of 2.40% for next 5-years, compared to annual growth of -37.20% made by the stock over the past 5-years.
Analysts at 5 brokerage firms have issued recommendations for the Precigen Inc. (PGEN)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.70. Out of those 5 Wall Street analysts, 4 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Leave a Reply